UBS Group AG - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 167 filers reported holding IMMUNOMEDICS INC in Q4 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS Group AG ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$26,635,000
+1007.5%
313,242
+361.7%
0.01%
+900.0%
Q2 2020$2,405,000
+343.7%
67,848
+68.8%
0.00%
Q1 2020$542,000
-85.2%
40,201
-76.8%
0.00%
-100.0%
Q4 2019$3,661,000
-33.1%
172,979
-58.1%
0.00%
-50.0%
Q3 2019$5,472,000
+70.7%
412,661
+78.6%
0.00%
+100.0%
Q2 2019$3,205,000
+2464.0%
231,022
+3429.7%
0.00%
Q1 2019$125,000
-92.2%
6,545
-94.2%
0.00%
-100.0%
Q4 2018$1,600,000
+44.3%
112,153
+110.7%
0.00%
Q3 2018$1,109,000
+395.1%
53,226
+463.2%
0.00%
Q2 2018$224,000
-91.9%
9,451
-95.0%
0.00%
-100.0%
Q1 2018$2,765,000
-52.5%
189,230
-47.4%
0.00%
-50.0%
Q4 2017$5,818,000
+32.3%
359,970
+14.5%
0.00%0.0%
Q3 2017$4,397,000
+609.2%
314,475
+348.2%
0.00%
Q2 2017$620,000
+2483.3%
70,164
+1796.3%
0.00%
Q1 2017$24,000
+140.0%
3,700
+37.0%
0.00%
Q4 2016$10,000
+11.1%
2,7000.0%0.00%
Q3 2016$9,000
-83.9%
2,700
-88.7%
0.00%
Q2 2016$56,000
+86.7%
23,992
+98.5%
0.00%
Q1 2016$30,000
-85.1%
12,089
-81.6%
0.00%
Q4 2015$201,000
+111.6%
65,563
+18.9%
0.00%
Q3 2015$95,000
-64.4%
55,150
-16.2%
0.00%
Q2 2015$267,000
+6.0%
65,7900.0%0.00%
Q1 2015$252,000
-44.0%
65,790
-29.8%
0.00%
Q4 2014$450,00093,7800.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of IMMUNOMEDICS INC shareholders